---
url: "https://www.lek.com/leadership/sej-brar"
title: "Sej Brar | L.E.K. Consulting"
---

[Skip to main content](https://www.lek.com/leadership/sej-brar#main-content)

[![L.E.K.](https://www.lek.com/themes/lek/images/new-logo.svg)](https://www.lek.com/ "L.E.K.")

Search

- English
- List additional actions
- [Português](https://www.lek.com/pt-br/lek-brazil)
- [简体中文](https://www.lek.com/zh-hant/lek-china)
- [Deutsch](https://www.lek.com/de/lek-germany)
- [日本語](https://www.lek.com/ja/lek-japan)

# Sej Brar

Sej Brar is a Partner in L.E.K. Consulting’s London office and is a member of the Life Sciences & Pharma practice.

Sej has over 12 years of consulting experience, and his work has spanned many client types, including large-cap global companies, midcap/specialty players and financial sponsors, such as hedge funds and private equity funds. He has a particular focus on working with biopharma and medical devices companies to deliver projects in corporate strategy, investment advisory, and Organization & Performance (O&P). Key areas of expertise include franchise/product strategy, growth strategy, business development/transaction support, commercial excellence and organizational effectiveness.

Before joining L.E.K., Sej worked in strategy consulting at the Monitor Group and Deloitte. He holds a Master of Business Administration with Distinction from Harvard Business School and a B.A., Cum Laude, in Economics and International Relations from Tufts University.

### Education

**Undergraduate:** B.A., Cum Laude, in Economics and International Relations, Tufts University

**Graduate:** Master of Business Administration with Distinction, Harvard Business School

![Sej Brar, L.E.K. Consulting](https://www.lek.com/sites/default/files/profile-images/sej-brar_web.jpg)

### Sej's Expertise

#### Industries

[Biotech and Pharmaceuticals](https://www.lek.com/industries/life-sciences-pharma/biotech-pharmaceutical)

[Pharma Services](https://www.lek.com/industries/life-sciences-pharma/pharma-services)

[MedTech](https://www.lek.com/industries/medtech)

[Procedure-Specific Devices](https://www.lek.com/industries/medtech/procedure-specific-medical-devices)

#### Capabilities

[Strategy](https://www.lek.com/capabilities/strategy)

[Organization & Performance](https://www.lek.com/capabilities/organization-performance)

[Marketing & Sales](https://www.lek.com/capabilities/marketing-and-sales)

Read more

### Related Insights

[Executive Insights\\
\\
\\
**Healthcare****The Race Is On: Winning Smart in the Intensifying GLP-1 Market in China**\\
\\
May 15, 2025](https://www.lek.com/insights/hea/cn/ei/race-winning-smart-intensifying-glp-1-market-china)

[Executive Insights\\
\\
\\
**Life Sciences & Pharma****Quantum Computing in Biopharma: Future Prospects and Strategic Insights**\\
\\
May 1, 2025](https://www.lek.com/insights/hea/us/ei/quantum-computing-biopharma-future-prospects-and-strategic-insights)

[Case Study\\
\\
\\
**Biotech and Pharmaceuticals****Late Lifecycle Strategy Assessment for a Biologic**\\
\\
April 30, 2024](https://www.lek.com/insights/hea/global/cs/late-lifecycle-strategy-assessment-biologic)

[Executive Insights\\
\\
\\
**Biotech and Pharmaceuticals****Five Essential Factors for a Successful Biopharma Product Launch**\\
\\
September 30, 2022](https://www.lek.com/insights/ei/five-essential-factors-successful-biopharma-product-launch)

[Article\\
\\
\\
**Life Sciences & Pharma****ASCO 2021 Social Listening: Major Data Readouts and Themes**\\
\\
July 27, 2021\\
\\
L.E.K. Consulting used social listening to gauge the sentiment of virtual attendees at the ASCO 2021 meeting.](https://www.lek.com/insights/ar/asco-2021-social-listening-major-data-readouts-and-themes)

[Executive Insights\\
\\
\\
**Life Sciences & Pharma****European Drug Pricing and Market Access in a COVID-19 World**\\
\\
October 14, 2020\\
\\
On 3 June 2020, Médecins Sans Frontières (MSF) issued an appeal urging world leaders to ensure that pharmaceutical companies sell any COVID-19 vaccines at…](https://www.lek.com/insights/ei/european-drug-pricing-and-market-access-covid-19-world)

- [Load more](https://www.lek.com/leadership/sej-brar?page=1 "Load more items")

### Medical Affairs

Sej Brar describes what it takes to reshape and transform the strategic relevance of the medical affairs function.


Medical Affairs

![](https://fast.wistia.net/embed/medias/km1z32s51e/swatch)

![Video Thumbnail](https://fast.wistia.net/embed/medias/km1z32s51e/swatch)

![Video Thumbnail](https://embed-ssl.wistia.com/deliveries/a6cae98638bd4514a3ef7c97430c12fd641e172a.webp?image_crop_resized=1920x1080)

Click for sound

2:35

![Sej Brar ](https://www.lek.com/sites/default/files/teaser-images/Sej-brar-teaser-image.png)

##### Life Sciences & Pharma

#### Medical Affairs

First name

Last name

Email

Phone number

My locationUnited StatesCanadaAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzech RepublicCôte d’IvoireDemocratic Republic of the CongoDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHondurasHong Kong S.A.R., ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao S.A.R., ChinaMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinian TerritoryPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVaticanVenezuelaViet NamWallis and FutunaWestern SaharaYemenZambiaZimbabwe

Reason for contactingBusiness - I'm exploring hiring L.E.K.Press - I'm a media representative seeking an L.E.K. expert perspectiveCareer - I'm exploring working at L.E.K.Events - I'm looking to invite L.E.K. to participate in an upcoming eventOther

Company

Message

Comments

By clicking “Contact me” I acknowledge and agree to the L.E.K. Consulting [Privacy Notice](https://www.lek.com/lek-consulting-privacy-policy).

×